Which Peptide Leaders Are Attending in 2026?
Discover the companies joining the 3rd Peptide-Based Therapeutics Summit 2026. Featuring organisations represented by our speakers and delegates, this page reflects the diverse community of leaders, innovators, and decision-makers attending the event.
20n Bio
A*STAR
Aanastra Inc
Abbvie
AI Proteins
Aizen Therapeutics
Akros Pharma Inc
Alnylam Pharmaceuticals
ANYA BIOPHARM
Arrowhead Pharmaceuticals, Inc.
Ashland Inc
AstraZeneca
Asymchem Laboratories (Tianjin) Co., Ltd
Bachem
Bayer
Biogen
BioLogue / University of Copenhagen
Biotage
Catalent, Inc
Chugai Pharmaceuticals
Circle Pharma
Concept Life Sciences
Corden Pharma
Curie.Bio
Cyrpumed
Decoy Therapeutics
Divincell
Eli Lilly
Endevica bio
EPOC Scientific
evonik
Feldan Therapeutics
Foley Hoag LLP
Funpep
Grove Biopharma
Gyros Protein Technologies AB
Hansoh Bio
Johnson & Johnson
Kissaki Biosciences
Lonza
Maestro Therapeutics
Mariana Oncology
MBX Bioscience
Merck
MIT
New England BioLabs Inc
Novartis Institutes for BioMedical Research (NIBR)
Novo Nordisk
Ono Pharmaceutical Co
Ormoni Biosciences
Parabilis Medicines
PepLib
Pepticom Ltd.
Peptinovo Biopharma
Perpetual Medicines
Pfizer
Pinnacle Medicines
PMV Pharmaceuticals Inc
Protagonist Therapeutics, Inc.
ProteinQure
Rapafusyn
RECEPTOR.AI
Sapience Therapeutics
Schrodinger Inc
Shionogi Inc.
Stealth Mode Biotech
SynCrest
Tokyo University of Science
U.S. Pharmacopeia
UCB
University College Dublin
Unnatural Products
Vida
Vilya
Viva Biotech Ltd
Vivtex
Xeris Pharmaceuticals, Inc.
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.